Nampak Limited:企業の戦略・SWOT・財務情報

◆英語タイトル:Nampak Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C12971
◆発行会社(調査会社):MarketLine
◆発行日:2019年1月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:南アフリカ
◆産業分野:紙・包装
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Nampak Limited – Strategy, SWOT and Corporate Finance Report
Summary

Nampak Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Nampak Limited (Nampak) is a diversified packaging company. It manufactures metal, paper and plastic packaging products. The company’s product portfolio includes beverage cans, tinplate food cans, paper sacks, polyethylene terephthalate (PET) bottles and plastic closures, crates, tubes, drums, high-density polyethylene (HDPE) bottles. Nampak serves several markets such as personal care, tobacco, processed food, poultry, beverages, agriculture, chemical, petroleum, household, confectionery, industrial, dairy, and paint. It operates manufacturing facilities in South Africa, the UK, Angola, Botswana, Nigeria, Ethiopia, Kenya, Zambia, Malawi, Zimbabwe and Ireland. Nampak is headquartered in Sandton, Gauteng, South Africa.

Scope

- Detailed information on Nampak Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Nampak Limited in the form of a SWOT analysis
- An in-depth view of the business model of Nampak Limited including a breakdown and examination of key business segments
- Intelligence on Nampak Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Nampak Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Nampak Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Nampak Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Nampak Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Nampak Limited: Company Overview
Nampak Limited: Overview and Key Facts
Nampak Limited: Overview
Nampak Limited: Key Facts
Nampak Limited: Key Employees
Nampak Limited: Key Employee Biographies
Nampak Limited: Major Products and Services
Nampak Limited: Company History
Nampak Limited: Management Statement
Nampak Limited: Locations and Subsidiaries
Nampak Limited: Key Competitors
Nampak Limited: Company Analysis
Nampak Limited: Business Description
Nampak Limited: SWOT Analysis
Nampak Limited: SWOT Overview
Nampak Limited: Strengths
Nampak Limited: Weaknesses
Nampak Limited: Opportunities
Nampak Limited: Threats
Nampak Limited: Corporate Financial Deals Activity
Nampak Limited: Financial Deals Overview
Nampak Limited: Targets and Partners
Nampak Limited: Top Deals 2015 – 2019YTD*
Nampak Limited: Mergers and Acquisitions
Nampak Limited: Divestments
Nampak Limited: Recent Developments
Nampak Limited: News and Events Summary
Nampak Limited: Business Expansion
Nampak Limited: Financial Performance
Nampak Limited: Market Developments
Nampak Limited: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Nampak Limited: Key Facts
Table 2: Nampak Limited: Key Employees
Table 3: Nampak Limited: Company History
Table 4: Nampak Limited: Locations and Subsidiaries
Table 5: Nampak Limited: Key Competitors
Table 6: Nampak Limited: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Nampak Limited: Targets and Partners
Table 8: Nampak Limited: Top Deals 2015 - 2019YTD*
Table 9: Nampak Limited: M&A Volume and Value Trend (2015 - YTD*2019)
Table 10: Nampak Limited: M&A Activity by Geography (2015 - YTD*2019)
Table 11: Nampak Limited: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 12: Nampak Limited: Divestments by Geography (2015 - YTD*2019)
Table 13: Nampak Limited: News and Events Summary
Table 14: Nampak Limited: Business Expansion
Table 15: Nampak Limited: Financial Performance
Table 16: Nampak Limited: Market Developments
Table 17: Nampak Limited: Strategy and Operations

List of Figures
Figure 1: Nampak Limited: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 2: Nampak Limited: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 3: Nampak Limited: M&A Activity by Geography (2015 - YTD*2019)
Figure 4: Nampak Limited: Divestments Volume and Value Trend (2015 - YTD*2019)
Figure 5: Nampak Limited: Divestments by Geography (2015 - YTD*2019)

★海外企業調査レポート[Nampak Limited:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Laboratorios Liomont SA de CV:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios Liomont SA de CV (Liomont) is a pharmaceutical company that develops medication products. The company offers prescription medication products, biotech products and over the counter products. It provides drugs in various therapeutic areas including analgesics, antiparasitic, anti …
  • Rexahn Pharmaceuticals Inc (RNN):企業の財務・戦略的SWOT分析
    Summary Rexahn Pharmaceuticals Inc (Rexahn Pharmaceuticals), formerly Corporate Road Show.com Inc is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer. The company develops anti-cancer drug candidates including Archexin that is intended for the tre …
  • Newfield Exploration Company:企業の戦略・SWOT・財務情報
    Newfield Exploration Company - Strategy, SWOT and Corporate Finance Report Summary Newfield Exploration Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Aeroports de Paris SA:戦略・SWOT・企業財務分析
    Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report Summary Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Metgasco Ltd (MEL):企業の財務・戦略的SWOT分析
    Summary Metgasco Ltd (Metgasco) is an oil and gas exploration company. The company that acquires, explores, produces, and develops oil and gas, petroleum and hydrocarbon assets. It holds interests in Clarence Moreton Basin, an exploration license located in northern New South Wales. Metgasco supplie …
  • Indian Oil Corp Ltd (IOC):石油・ガス:M&Aディール及び事業提携情報
    Summary Indian Oil Corp Ltd (IOCL) is an integrated oil and gas company that carries out exploration and production of oil and natural gas, refining of crude oil, pipeline transportation and marketing of natural gas and petroleum products. The company also produces and markets petrochemicals and has …
  • Daily Mail & General Trust plc (DMGT):企業の財務・戦略的SWOT分析
    Daily Mail & General Trust plc (DMGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • SOLX Inc:医療機器:M&Aディール及び事業提携情報
    Summary Solx Inc (SOLX) is a medical device company that develops therapeutic products. The company provides glaucoma surgery devices and treatments for glaucoma therapy. Its SOLX gold shunt is a minimally invasive device, which is used in surgical treatment of glaucoma. SOLX’s product is a gold imp …
  • Veloxis Pharmaceuticals AS (VELO):製薬・医療:M&Aディール及び事業提携情報
    Summary Veloxis Pharmaceuticals A/S (Veloxis) is a specialty pharmaceutical company that identifies, develops and commercializes pharmaceutical drugs in transplantation and adjacent therapies. The company developed ENVARSUS XR (tacrolimus extended-release tablets) for the prophylaxis of organ reject …
  • Zeria Pharmaceutical Co Ltd (4559):製薬・医療:M&Aディール及び事業提携情報
    Summary Zeria Pharmaceutical Co Ltd (Zeria), formerly Zeria Yakusho Kenkyusho Co Ltd is a pharmaceutical company that manufactures pharmaceutical and non-pharmaceuticals, veterinary pharmaceuticals, industrial chemicals and reagents. The company imports and exports healthcare products such as cosmet …
  • Paratek Pharmaceuticals Inc (PRTK):製薬・医療:M&Aディール及び事業提携情報
    Summary Paratek Pharmaceuticals Inc (Paratek) is a biopharmaceutical company that develops and commercializes therapies based on tetracycline chemistry. Omadacycline (antibiotic), the company’s lead product candidate is an aminomethylcycline which acts against gram-negative, gram-positive, and atypi …
  • Placon Corporation:企業の戦略・SWOT・財務情報
    Placon Corporation - Strategy, SWOT and Corporate Finance Report Summary Placon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SurModics Inc (SRDX):企業の財務・戦略的SWOT分析
    SurModics Inc (SRDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • TelaDoc Inc (TDOC):医療機器:M&Aディール及び事業提携情報
    Summary TelaDoc Inc (Teladoc) is a provider of telehealth services. The company offers short term prescription for amoxicillin, azithromycin, bactrim DS, augmentin, cipro, tessalon perles, flonase nasal spray, pyridium, prednisone and diflucan. It provides telehealth services for cold and flu sympto …
  • Hydrogenics Corporation (HYG)-エネルギー分野:企業M&A・提携分析
    Summary Hydrogenics Corporation (Hydrogenics) is a provider of power generation equipment. It designs, develops, and manufactures hydrogen generation, energy storage, and fuel cell products. The company produces products on water electrolysis technology and proton exchange membrane (PEM) technology. …
  • Komunalna poistovna, a.s. Vienna Insurance Group:企業の戦略的SWOT分析
    Komunalna poistovna, a.s. Vienna Insurance Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Molnlycke Health Care AB:企業の戦略的SWOT分析
    Molnlycke Health Care AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • eFFECTOR Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary eFFECTOR Therapeutics Inc (Effector) is a biopharmaceutical company that concentrates on new class of oncology drugs-selective translation regulators. The company works on the discovery and development of translation regulators as a new small molecule therapeutics that control gene expressio …
  • Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析
    Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Fletcher Building Ltd:戦略・SWOT・企業財務分析
    Fletcher Building Ltd - Strategy, SWOT and Corporate Finance Report Summary Fletcher Building Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆